Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: Time for change?

Internal Medicine Journal

Volumn 44, Issue 9, 2014, Pages 865-872

  Fagan, K J ^a,b   Zhao, E Y ^b   Horsfall, L U ^a,b   Ruffin, B J ^b   Kruger, M S ^b   McPhail, S M ^c,d   O'Rourke, P ^e   Ballard, E ^e   Irvine, K M ^b   Powell, Elizabeth E ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d Centre for Functioning and Health Research   (Australia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Chronic liver disease; Healthcare cost; Hospital readmission; Models of care; Paracentesis; Spontaneous bacterial peritonitis

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; DIURETIC AGENT; HEMOGLOBIN; LACTULOSE; PROPRANOLOL; PROTON PUMP INHIBITOR;

ACUTE KIDNEY FAILURE; ADULT; ALCOHOL CONSUMPTION; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CLINICAL ARTICLE; COHORT ANALYSIS; DATA BASE; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC IMAGING; DISEASE MARKER; DISEASE SEVERITY; DIURETIC THERAPY; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HOSPITAL BED; HOSPITAL READMISSION; HOSPITAL SERVICE; HOSPITALIZATION; HUMAN; HYPONATREMIA; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PARACENTESIS; PARAMETERS; RISK FACTOR; TERTIARY HEALTH CARE; AUSTRALIA; COMPLICATION; COST OF ILLNESS; ECONOMICS; FOLLOW UP; HEALTH CARE PLANNING; LIVER CIRRHOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TIME; UTILIZATION;

ASCITES; AUSTRALIA; COST OF ILLNESS; FEMALE; FOLLOW-UP STUDIES; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARACENTESIS; PATIENT READMISSION; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY HEALTHCARE; TIME FACTORS;

EID: 84912101768     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12491     Document Type: Article

References (33)

1. The Gastroenterological Society of Australia/Australian Liver Association. The economic cost and health burden of liver diseases in Australia. 2013. [cited 2014 Aug 3]. Available from URL: http://www.gesa.org.au/files/editor _upload/File/GESA%20report %2028032013_web.pdf
2. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36: 227-42.
3. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 2012; 107: 247-52.
4. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-8.
5. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-31.
6. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42.
7. Nousbaum JB, Cadranel JF, Nahon P, Khac EN, Moreau R, Thevenot T et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology 2007; 45: 1275-81.
8. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
9. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
10. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49: 2087-107.
11. Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol 2010; 8: 709-17.
12. Scott IA. Chronic disease management: a primer for physicians. Intern Med J 2008; 38: 427-37.
13. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-19.
14. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-50.
15. Anderson P, Cremona A, Paton A, Turner C, Wallace P. The risk of alcohol. Addiction 1993; 88: 1493-508.
16. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025-9.
17. Lelbach WK. Epidemiology of alcoholic liver disease. Prog Liver Dis 1976; 5: 494-515.
18. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
19. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
20. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008; 57: 252-7.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
22. Jepsen P, Vilstrup H, Lash TL. Development and validation of a comorbidity scoring system for patients with cirrhosis. Gastroenterology 2014; 146: 147-56.
23. Vergara M, Cleries M, Vela E, Bustins M, Miquel M, Campo R. Hospital mortality over time in patients with specific complications of cirrhosis. Liver Int 2013; 33: 828-33.
24. Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med 2011; 26: 1175-82.
25. Ganesh S, Rogal SS, Yadav D, Humar A, Behari J. Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis. PLoS ONE 2013; 8: e55140.
26. Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 2006; 101: 1490-6.
27. Thuluvath PJ. Higher prevalence and severity of hepatic encephalopathy in patients with HCV cirrhosis and diabetes mellitus: is presence of autonomic neuropathy the missing part of the puzzle? Am J Gastroenterol 2006; 101: 2244-6.
28. Fagan KJ, Irvine KM, Kumar S, Bates A, Horsfall LU, Feeney GF et al. Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early intervention. Intern Med J 2013; 43: 1096-102.
29. Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR Jr, Nguyen J et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol 2011; 9: 254-9.
30. Wigg AJ, McCormick R, Wundke R, Woodman RJ. Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol 2013; 11: 850-8 e1-4.
31. Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A et al. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol 2013; 59: 257-64.
32. Kanwal F, Kramer JR, Buchanan P, Asch SM, Assioun Y, Bacon BR et al. The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology 2012; 143: 70-7.
33. Bini EJ, Weinshel EH, Generoso R, Salman L, Dahr G, Pena-Sing I et al. Impact of gastroenterology consultation on the outcomes of patients admitted to the hospital with decompensated cirrhosis. Hepatology 2001; 34: 1089-95.